Clinica Medica Generale e Cardiologia - Ospedale Careggi
Florence, 50134, Italy
NCT Number: NCT00187252
The purpose of this study is to evaluate whether adding AF Suppression™ to cardiac resynchronization therapy (CRT) improves the prognosis of heart failure patients benefiting from cardiac resynchronization therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Florence, 50134, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pacemaker/ ICD implant
Time frame: 2 years
Abbott Medical Devices
Industry
Management of Atrial Fibrillation Suppression in AF-HF COmorbidity Therapy
Acronym: MASCOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT01420393
Arrhythmias, Cardiac, Atrial Fibrillation
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT07512310
Cardiovascular Diseases, Heart Diseases
Essen, Germany
View Trial DetailsNCT04461691
Arrhythmias, Cardiac, Atrial Fibrillation
Wiesbaden, Germany
View Trial Details